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Abstract: Earlier or preprocedural identification of occlusion pathomechanism is crucial for effective
endovascular treatment. As leptomeningeal collaterals tend to develop well in chronic ischemic
conditions such as intracranial atherosclerosis (ICAS), we investigated whether leptomeningeal
collaterals can be a preprocedural marker of ICAS-related large vessel occlusion (ICAS-LVO)
in endovascular treatment. A total of 226 patients who underwent endovascular treatment
were retrospectively reviewed. We compared the pattern of leptomeningeal collaterals between
patients with ICAS-LVO and without. Leptomeningeal collaterals were assessed by preprocedural
computed tomography angiography (CTA) and basically categorized by three different collateral
assessment methods. Better leptomeningeal collaterals were significantly associated with ICAS-LVO,
although they were not independent for ICAS-LVO. When leptomeningeal collaterals were
dichotomized to incomplete (<100%) and complete (100%), the latter was significantly more frequent
in patients with ICAS-LVO (52.5% versus 20.4%) and remained an independent factor for ICAS-LVO
(odds ratio, 3.32; 95% confidence interval, 1.52–7.26; p = 0.003). The area under the curve (AUC) value
of complete leptomeningeal collateral supply was 0.660 for discrimination of ICAS-LVO. Incomplete
leptomeningeal collateral supply was not likely ICAS-LVO, based on the high negative predictive
value (88.6%). Considering its negative predictive value and the independent association between
complete leptomeningeal collateral supply and ICAS-LVO, leptomeningeal collaterals could be helpful
in the preprocedural determination of occlusion pathomechanism.
Keywords: atherosclerosis; computed tomography angiography; stroke; thrombectomy
1. Introduction
Mechanical thrombectomy has been primarily considered in most cases of endovascular treatment
of acute intracranial large vessel occlusion [1]. However, mechanical thrombectomy might not be
an optimal modality for a specific occlusion pathomechanism—that is, an in situ thrombo-occlusion
of underlying intracranial atherosclerosis (intracranial atherosclerosis-related large vessel occlusion
(ICAS-LVO)) [2,3]. ICAS-LVO is not a rare condition. In the Asian population, up to 30% of
patients might have ICAS-LVO for their occlusion pathomechanism in endovascular treatment of
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anterior circulation [4]. More importantly, conventional mechanical thrombectomy modalities, such as
stent retriever and thrombaspiration, are ineffective in ICAS-LVO. Mechanical thrombectomy was
effective only in less than 20% of ICAS-LVO cases. Due to frequent reocclusion events, specific
rescue endovascular modalities (i.e., intra-arterial glycoprotein IIb/IIIa inhibitor, balloon angioplasty,
and intracranial stenting) were inevitable in most cases to achieve significant recanalization in
ICAS-LVO [5–9].
On this point, earlier strategical consideration is crucial to shorten the time to recanalization [4].
For earlier strategical consideration, it could be more helpful if the occlusion pathomechanism
is determined before endovascular treatment. However, the completion of such a preprocedural
determination is challenging as the information available before endovascular treatment can be limited.
In clinical practice, we are able to rely on only a few preprocedural clinical and imaging findings [7,10].
However, further reliable methods are sparse.
Leptomeningeal collaterals are one of the preprocedural factors which are potentially able to
predict occlusion pathomechanism. Nevertheless, their association has not been clearly evaluated
yet. Several experimental and clinical findings led us to focus on leptomeningeal collaterals. In these
experimental findings, the vascular bed was more developed in chronic or long-term ischemic
conditions [11–13]. Similarly, in patients with an intracranial stenosis due to ICAS, leptomeningeal
collaterals were prominently developed to compensate for the diminished cerebral blood flow under
chronic ischemia [11,12]. In one report, full and rapid leptomeningeal collateral filling was commented
on as a finding, which suggests ICAS-LVO [7]. However, no specific evidence supported this comment.
Instead, it was reported that initial infarct volume was smaller among patients with an ICAS-LVO.
This merely indirectly suggested that leptomeningeal collaterals were better in ICAS-LVO [7,14].
If leptomeningeal collaterals are discriminatorily developed in patients with ICAS, we believe that
they may be an indirect finding for ICAS-LVO. Thus, we hypothesized that (1) leptomeningeal collaterals
would be different according to the occlusion pathomechanism—that is, robust or better leptomeningeal
collaterals are associated with ICAS-LVO, and (2) based on this association, we could predict ICAS-LVO
before endovascular treatment. Accordingly, this study aimed to evaluate (1) the association between
leptomeningeal collaterals and ICAS-LVO, and (2) the predictability of preprocedural leptomeningeal
collaterals for ICAS-LVO.
2. Methods
We retrospectively reviewed consecutive acute stroke patients between January 2010 and December
2018 who underwent endovascular treatment of intracranial vessel occlusion. Patients were selected
from a prospective registry of a tertiary stroke center (Severance Stroke Center, Severance Hospital, Seoul,
Korea). The registry consists of consecutive patients who underwent endovascular treatment, which
was considered by the following criteria: (1) a computed tomography angiography (CTA)-determined,
endovascularly accessible intracranial LVO associated with neurological symptoms; (2) within 8 h
from stroke onset, though, in the later study period, patients falling within the window of 8 h to 12 h
from stroke onset were also considered if they had an Alberta Stroke Program Early CT Score of seven
points or more on initial non-contrast CT; and (3) a baseline National Institutes of Health Stroke Scale
(NIHSS) score of four points or more. For patients eligible for intravenous tissue-type plasminogen
activator treatment, the full dose of tissue-type plasminogen activator (0.9 mg/kg) was administered.
For this study, patients who had an M1 occlusion and CTA performed before endovascular
treatment were selected from the registry. Conversely, those who presented with an internal carotid
artery occlusion were excluded, as collateral flows through anterior or posterior communicating
arteries can contribute to lesion-side cerebral flow. Additionally, patients with an occlusion of the
distal artery or posterior circulation were also excluded because leptomeningeal collaterals could not
be determined reliably in this population. We did not include patients with multiple intracranial artery
occlusions because they could also affect leptomeningeal collaterals on middle cerebral artery territory.
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The institutional review board approved this study and waived the requirement for obtaining
informed consent prior to study inclusion based on the retrospective design.
2.1. Assessment of Leptomeningeal Collaterals (Collateral Assessment Methods)
Leptomeningeal collaterals were determined by CTA performed immediately before endovascular
treatment. CTA collateral grade was assessed on 20-mm thickness maximum intensity projection
images of single-phase CTA. In patients who underwent multiphase CTA imaging, we only used the
first-phase images to evaluate leptomeningeal collaterals.
From among the various existing CTA-based collateral assessment methods, three different
methods were adopted [15–17]. First, leptomeningeal collaterals were primarily assessed by a
four-scale method previously reported as follows: (1) absent collateral supply to the occluded middle
cerebral artery (MCA) territory of 0%, (2) collateral supply of greater than 0% but less than or equal to
50%, (3) collateral supply of greater than 50% but less than 100%, and (4) complete collateral supply
of 100% (collateral assessment method 1; Tan’s method; Figure 1) [15]. Second, the four grades were
regrouped into a three-scale grade system as follows: (1) absent collateral supply to the occluded MCA
territory of 0%, (2) collateral supply of greater than 0% but less than 100%, and (3) complete collateral
supply of 100% (collateral assessment method 2; shortened from Mass’ method) [16]. Third, the four
grades were simply dichotomized into (1) collateral supply of 50% or less of the occluded MCA territory
and (2) collateral supply of more than 50% (collateral assessment method 3; modified Tan’s method) [17].
The four-scale grade of leptomeningeal collaterals was determined by two independent interventional
neuroradiologists who were blinded to the clinical and procedural information. The kappa value for
the interrater agreement was 0.85 (95% confidence interval, 0.79–0.91), which was similar to its original
report [15]. Discrepant cases were resolved by consensus.
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Figure 1. Assessment of leptomeningeal collaterals according to collateral assessment method 1
(Tan et al.’s method). Four computed tomography angiography maximum intensity projection axial
images from different patients showing leptomeningeal collaterals. (A) Absent collateral supply
to the occluded middle cerebral artery territory (circle), compared to the contralateral normal side.
(B) Collateral supply of greater than 0% but less than or equal to 50%. (C) Collateral supply of greater
than 50% but less than 100%. (D) Complete collateral supply of 100%.
2.2. Identification of ICAS-LVO
ICAS-LVO was determined angiographically. If the occlusion site was completely recanalized
without any residual stenosis and reocclusion tendency, the occlusion pathomechanism was not
considered as ICAS. In contrast, when significant fixed focal stenosis was noted on angiography,
the case was considered as positive for ICAS-LVO [7]. For intractable cases whose occlusion
was never recanalized, so that the focal stenosis could not be evaluated, occlusion at the arterial
trunk was determined as indicative of ICAS-LVO [6]. ICAS-LVO was assessed independently by
two other interventional neuroradiologists who were blinded to the CTA findings and clinical
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information. The kappa value for the interrater agreement was 0.92 (95% confidence interval, 0.86–0.98).
Discrepant cases were also resolved by consensus.
2.3. Statistical Analysis
Based on the identification of ICAS-LVO, patients were assigned to the ICAS group or the non-ICAS
group. First, we evaluated the association between leptomeningeal collaterals as determined by the
three collateral assessment methods and ICAS-LVO. In this process, (1) basic demographics (age and
sex), risk factors for atherosclerosis (hypertension diabetes, dyslipidemia, smoking, and coronary
artery disease), typical clinical factors associated with occlusion pathomechanism (atrial fibrillation
and initial NIHSS score), and leptomeningeal collaterals by each collateral assessment method were
compared between the ICAS and non-ICAS groups. The Mann–Whitney U test, chi-squared test,
and Fisher’s exact test were used for comparison. Also, we summarized the study population by
descriptive statistics. Continuous variables were expressed by a mean value with standard deviation
or a median value with interquartile range, as appropriate. Categorical variables were expressed
by a frequency with its percentage. Then, (2) to see whether better leptomeningeal collaterals were
associated with ICAS-LVO, we performed binary logistic regression analyses for each collateral
assessment method. To determine whether better leptomeningeal collaterals can be an independent
variable for ICAS-LVO, variables with a p-value < 0.10 in the univariable analysis were entered into
the multivariable model. Finally, (3) to evaluate the predictive power of leptomeningeal collaterals for
ICAS-LVO, we calculated the sensitivity, specificity, positive predictive value (PPV), negative predictive
value (NPV), and accuracy of each collateral assessment method. Receiver operating characteristic
curve analyses were also performed to calculate the area under the curve (AUC) values and cutoff
points, which were determined based on Youden’s index.
Second, based on the results of logistic regression analyses and calculated cutoff points of each
collateral assessment method, leptomeningeal collaterals were dichotomized into (1) incomplete
collateral supply of less than 100% or (2) complete collateral supply of 100%. Then, the findings of
complete and incomplete collateral supplies were compared between the ICAS and non-ICAS groups.
To see whether complete leptomeningeal collateral supply was associated with ICAS-LVO, univariable
and multivariable binary logistic regression analyses were performed in the same manner as the three
collateral assessment methods. We also calculated sensitivity, PPV, NPV, accuracy, and AUC value for
the dichotomization in predicting ICAS-LVO.
A p-value < 0.05 was considered statistically significant for the 95% confidence interval.
All statistical analyses were performed using R software (version 3.5.0; R Foundation for Statistical
Computing, Vienna, Austria).
3. Results
Among the 604 patients that underwent endovascular treatment for an intracranial vessel
occlusion, 226 patients (mean age 69.0 ± 12.1 years; 54.4% male) were included (Figure 2). Patients with
arterial dissection (n = 5), distal artery occlusion (n = 132), internal carotid artery occlusion (n = 154),
and vertebrobasilar artery occlusion (n = 79) were excluded. In eight patients, leptomeningeal
collaterals could not be determined by CTA because the arterial target was changed between CTA and
endovascular treatment (n = 2; internal carotid artery occlusion on initial CTA was changed to M1
occlusion on cerebral angiography) or CTA was not performed before endovascular treatment (n = 6).
Leptomeningeal collaterals were 0% in the occluded MCA territory in 15 patients (6.6%), greater than
0% but less than or equal to 50% in 57 (25.2%), greater than 50% but less than 100% in 95 (42.1%),
and 100% in 59 (26.1%).
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Figure 2. Patients selection flow chart. DSA, digital subtraction angiography.
3.1. Association Between Leptomeningeal Collaterals and ICAS-LVO
A total of 40 patients (17.7%) showed an ICAS-LVO as the occlusion pathomechanism. Based on
the use of collateral assessment methods 1 and 2, patients with leptomeningeal collaterals of 0%, greater
t an 0% but less than or equal to 50%, and greater than 50% but less than 100% of occluded MCA
territory were less common in the ICAS group, whereas cases of complete (100%) leptomeningeal
collaterals were significantly more frequently found in the ICAS group (52.5% versus 20.4%; p < 0.001;
Table 1). For collateral assessment method 3, more patie ts in the ICAS group had leptomeningeal
collaterals of greater than 50% than the non-ICAS group (85.0% versus 64.5%; p = 0.012).
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Hypertension 166 (73.5) 32 (80.0) 134 (72.0) 0.301
Diabetes 66 (29.2) 13 (32.5) 53 (28.5) 0.613
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0% 15 (6.6) 1 (2.5) 14 (7.5) <0.001
>0% but ≤50% 57 (25.2) 5 (12.5) 52 (28.0)
>50% but <100% 95 (42.1) 13 (32.5) 82 (44.1)
100% 59 (26.1) 21 (52.5) 38 (20.4)
Method 2 (shortened Maas)
0% 15 (6.6) 1 (2.5) 14 (7.5) <0.001
>0% but <100% 152 (67.3) 18 (45.0) 134 (72.1)
100% 59 (26.1) 21 (52.5) 38 (20.4)
Method 3 (modified Tan)
≤50% 72 (31.9) 6 (15.0) 66 (35.5) 0.012
>50% 154 (68.1) 34 (85.0) 120 (64.5)
Dichotomization by cutoff
Incomplete (<100%) 167 (73.9) 19 (47.5) 148 (79.6) <0.001
Complete (100%) 59 (26.1) 21 (52.5) 38 (20.4)
Age is represented by a mean value (±standard deviation); initial National Institutes of Health Stroke Scale (NIHSS)
score by a median value (first and third quartile); all other variables by the number of patients (frequency, %).
On the logistic regression analyses for collateral assessment methods 1, 2, and 3, odds ratios for
ICAS-LVO gradually increased as leptomeningeal collaterals improved (Figure 3). However, none were
statistically significant in univariable and multivariable analyses (Table S1 and Figure 3).
For multivariable analyses, each collateral assessment method was adjusted by current smoking, atrial
fibrillation, and initial NIHSS score.
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3.2. Predictive Power of Leptomeningeal Collaterals for ICAS-LVO
For collateral assessment methods 1 and 2, the calculated sensitivity, specificity, PPV, and NPV of
leptomeningeal collaterals to predict ICAS-LVO were 52.5%, 79.6%, 35.6%, and 88.6%, respectively
(Table 2). Collateral assessment method 3 showed higher sensitivity and lower specificity for ICAS-LVO
than collateral assessment methods 1 and 2. AUC values of leptomeningeal collaterals were below 0.7
for all collateral assessment methods (each p < 0.001).
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Table 2. Diagnostic performance of leptomeningeal collaterals for intracranial atherosclerosis-related
large vessel occlusion.
Collateral Assessment
Methods Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%) AUC
Method 1 (Tan) 1 52.5 79.6 35.6 88.6 74.8 0.686
Method 2 (shortened Maas) 1 52.5 79.6 35.6 88.6 74.8 0.668
Method 3 (modified Tan) 2 85.0 35.5 22.1 91.7 44.2 0.602
Dichotomization by cutoff 1 52.5 79.6 35.6 88.6 74.8 0.660
1 For leptomeningeal collaterals of 100%; 2 for leptomeningeal collaterals of > 50%; PPV, positive predictive value;
NPV, negative predictive value; AUC, area under curve.
3.3. Significance of Complete Leptomeningeal Collaterals in Predicting ICAS-LVO
Based on the results from the analyses of collateral assessment methods 1, 2, and 3, study
participants’ leptomeningeal collaterals were dichotomized to incomplete (less than 100%) and
complete (100%). Patients in the ICAS group showed more complete leptomeningeal collateral supply
(p < 0.001; Table 1). During multivariable analysis, complete leptomeningeal collateral supply remained
an independent factor for ICAS-LVO (odds ratio, 3.32; 95% confidence interval, 1.52–7.26; p = 0.003;
Table S1 and Figure 3). An AUC value for complete leptomeningeal collaterals was 0.660 (95% CI,
0.595–0.722; p < 0.001), with an NPV of 88.6% (Table 2).
4. Discussion
In this study, we found that leptomeningeal collaterals were associated with occlusion
pathomechanism. Better leptomeningeal collaterals were significantly associated with ICAS-LVO in
common collateral assessment methods. Nevertheless, during logistic regression analyses, only the
use of a dichotomization method (incomplete versus complete) was independently associated with
ICAS-LVO. Despite the independence, it achieved only a modest degree of predictability of ICAS-LVO.
To the best of our knowledge, this study is the first study to evaluate the association of leptomeningeal
collaterals with ICAS-LVO and its preprocedural possibility to predict ICAS-LVO.
This study was originally contrived from the necessity to enhance the preprocedural determination
of occlusion pathomechanism in endovascular treatment of LVO. Because the optimal endovascular
strategy—which includes selection of the most effective endovascular modality and when to switch
from one modality to another—depends on the type of occlusion pathomechanism, the earlier
determination of occlusion pathomechanism can be crucial in attaining significant recanalization [18,19].
However, unfortunately, there have been only a few practical factors identified that we can rely on
to identify occlusion pathomechanism before an endovascular procedure. Common cardioembolic
sources such as atrial fibrillation or valvular heart diseases are typically considered as evidence of an
embolic occlusion of an intracranial artery [7]. Specific imaging findings—for example, a hyperdense
artery sign on CT or a blooming artifact on magnetic resonance imaging—have also been regarded as
markers of embolic occlusion [14,20]. Uniquely, the occlusion type observed on preprocedural CTA
was significantly associated with occlusion pathomechanism. The occlusion type was superior to
the atrial fibrillation and hyperdense artery sign in predicting the occlusion pathomechanism [10].
Patient demographics or a few risk factors for atherosclerosis can be referred to in order to assume
the occlusion pathomechanism; however, they are quite indirect means [7]. Particular infarct patterns
could also be helpful in determining the occlusion pathomechanism. However, the infarct pattern is
less evident and may be limited in the preprocedural condition [14].
As we expected, leptomeningeal collaterals were significantly associated with occlusion
pathomechanism in this study. In particular, complete leptomeningeal collaterals were consistently
associated with ICAS-LVO with a modest level of predictability. In comparison with other preprocedural
findings used to predict ICAS-LVO, the discriminative power of complete leptomeningeal collaterals
seemed not so inferior. In this study population, the AUC value of complete leptomeningeal collaterals
for ICAS-LVO was not lower than that of atrial fibrillation (0.653; 95% confidence interval, 0.587–0.715).
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Furthermore, the AUC value of CTA-determined occlusion type for stent retriever success, one of the
preprocedural findings presumed to be highly associated with ICAS-LVO, was less than 0.7 [5].
To the best of our knowledge, only one other study has commented on the association between
leptomeningeal collaterals and ICAS-LVO in endovascular treatment [7]. In the literature, full and rapid
leptomeningeal collaterals were significantly more frequent in patients with ICAS-LVO, which was
consistent with our study. However, the result was unofficial from a small number of patients, so it
was merely a piece of unpublished data in a review article. Additionally, leptomeningeal collaterals
were not considered as a predictor of ICAS-LVO in the literature. Leptomeningeal collaterals were
assessed by initial cerebral angiogram during endovascular treatment, not preprocedurally.
Complete leptomeningeal collaterals showed low sensitivity and PPV with a relatively higher
NPV in discriminating ICAS-LVO. For practical use, the statistical parameters can be interpreted as
follows: (1) in patients with ICAS-LVO, the probability of showing complete leptomeningeal collaterals
was about 50% (low sensitivity); (2) even among cases showing complete leptomeningeal collaterals,
ICAS-LVO was only present in about 40% of them (low PPV); and (3) if a patient showed incomplete
leptomeningeal collaterals, occlusion pathomechanism was not likely to be ICAS-LVO up to 90%
(high NPV).
The study results might be substantially affected by the chosen collateral assessment method.
However, there has been no consensual grading system established to evaluate leptomeningeal
collaterals on CTA. To avoid arbitrary grading, we tried to choose collateral assessment methods
that have all been widely used in previous studies [21,22]. Based on the consistent findings from
those collateral assessment methods, we regrouped the leptomeningeal collaterals by its cutoff
value into incomplete or complete. Cerebral angiography can be a good modality with which to
assess leptomeningeal collaterals. However, in most endovascular procedures, initial leptomeningeal
collateral flow is not assessed on cerebral angiography because the arterial target is directly approached
without taking the angiography of other cerebral vessels. We think that CTA might be the most rational
modality to use to assess leptomeningeal collaterals in daily clinical practice. Multiphase CTA could
be another collateral assessment method. However, multiphase CTA cannot be deployed in all centers;
indeed, multiphase CTA was not performed in the early period of this study.
This study had a few limitations. First, it was performed retrospectively in a single tertiary
stroke center. However, all patients were prospectively registered with a detailed description of their
endovascular procedure. Furthermore, this study focused on objective findings, including imaging
markers and angiographic findings rather than on clinical outcomes, thereby minimizing this limitation.
Nevertheless, based on the retrospective nature of this study, there might be a possibility that the
patients with better leptomeningeal collaterals were preferentially chosen for endovascular treatment.
Although the predetermined protocol in our center did not regulate the leptomeningeal collateral
status for endovascular treatment eligibility, the physician’s clinical decision might be partly affected
by the leptomeningeal collateral status.
Second, this study included patients only with M1 occlusion. Thus, the generalization of our
study results to all anterior circulation strokes might be inappropriate. However, as described earlier,
such use of this strict inclusion criterion was to ensure the improved evaluation of uncontaminated
leptomeningeal collaterals. Study findings should be understood as providing verification of a
general hypothesis that better leptomeningeal collaterals are associated with ICAS-LVO. In addition,
generalization of the study results could also be limited because this study was performed in an Asian
country where ICAS is more prevalent. As statistical power might be affected by the number of patients
with ICAS-LVO, no one could precisely figure out the association of leptomeningeal collaterals with
ICAS-LVO in other countries where ICAS is much less prevalent.
Third, this study also included patients with a tandem occlusion (M1 occlusion with cervical ICA
occlusion/stenosis). Chronic ischemia, even due to severe cervical ICA stenosis, might be associated
with robust leptomeningeal collaterals. Thus, theoretically, for the tandem occlusion, leptomeningeal
collaterals could be abundant or complete, although its M1 occlusion is embolic from a cervical ICA
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lesion. In fact, about 5% patients of this study had an atherosclerotic cervical ICA occlusion. Fortunately,
even after excluding the patients with tandem occlusions, the significance of the study results was
not changed.
5. Conclusions
Leptomeningeal collaterals determined by preprocedural CTA were significantly associated with
occlusion pathomechanism. Specifically, complete leptomeningeal collateral supply was independently
associated with ICAS-LVO. Despite the association, however, leptomeningeal collaterals were simply
predictive of ICAS-LVO in a modest degree. In clinical practice, one could assume that incomplete
leptomeningeal collateral supply is not likely ICAS-LVO based on high NPV. In this way, leptomeningeal
collaterals could be helpful in the preprocedural determination of occlusion pathomechanism.
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